Dr. Christine Chung, MD

• Medical Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Nc Hosps

  Residency Hospital

• English

• Korean

• Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome, 2021-07-02

• A Randomized Phase II Trial of Combined Nivolumab and Ipilimumab with or without Stereotactic Body Radiation Therapy for Advanced Merkel Cell Carcinoma, 2022-09-12

• Chromosomal instability drives metastasis through a cytosolic DNA response, 2018-01-17

• Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology, 2017-01-19

• SMAD4 loss is associated with cetuximab resistance and induction of MAPK/JNK activation in head and neck cancer cells, 2017-05-18

• Targeting the Hedgehog Pathway Using Itraconazole to Prevent Progression of Barrett's Esophagus to Invasive Esophageal Adenocarcinoma, 2021-06-01

• Ultrasound characterization for thyroid nodules with indeterminate cytology: inter-observer agreement and impact of combining pattern-based and scoring-based classifications in risk stratification, 2019-07-12

• Considerations for developing supportive care interventions for survivors of head and neck cancer: a qualitative study, 2022-07-03

• Oral Gargle-Tumor Biopsy Human Papillomavirus (HPV) Agreement and Associated Factors Among Oropharyngeal Squamous Cell Carcinoma (OPSCC) Cases, 2019-04-03

• EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma, 2023-05-22

• Model-informed experimental design recommendations for distinguishing intrinsic and acquired targeted therapeutic resistance in head and neck cancer, 2022-09-08

• CancerInSilico: An R/Bioconductor package for combining mathematical and statistical modeling to simulate time course bulk and single cell gene expression data in cancer, 2019-04-19

• Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial, 2023-04-03

• lncDIFF: a novel quasi-likelihood method for differential expression analysis of non-coding RNA, 2019-07-02

• Effects of checkpoint kinase 1 inhibition by prexasertib on the tumor immune microenvironment of head and neck squamous cell carcinoma, 2020-12-30

• Deep Learning of Histopathology Images at the Single Cell Level Deep Learning of Histopathology Images, 2021-09-10

• Effects of tobacco smoking on the tumor immune microenvironment in head and neck squamous cell carcinoma, 2019-12-17

• Impact of oncogene panel results on surgical management of cytologically indeterminate thyroid nodules, 2018-04-06

• Utilizing a large-scale biobanking registry to assess patient priorities and preferences for cancer research and education, 2021-02-05

• Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study, 2021-03-09

• Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma, 2021-01-18

• PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinoma, 2019-03-04

• A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced stage III/IVa/IVb head and neck squamous cell carcinoma, 2015-12-17

• lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/ß-catenin signaling, 2017-10-16

• KRAS-variant is a biomarker of cetuximab response potentially through altered immunity in head and neck cancer: Re-analysis of NRG Oncology/RTOG 0522 Subtitle: TheKRAS-variant and cetuximab response in HNSCC, 2017-04-01

• Virtual alignment of pathology image series for multi-gigapixel whole slide images, 2023-07-26

• A phase I/II study of rovalpituzumab tesirine in delta-like 3-expressing advanced solid tumors, 2021-08-05

• Methylation of HPV 16 andEPB41L3in oral gargles: Associations with oropharyngeal cancer detection and tumor characteristics, 2019-07-26

• Methylation of HPV16 andEPB41L3in oral gargles and the detection of early and late oropharyngeal cancer, 2022-05-26

• Integrated time course omics analysis distinguishes immediate therapeutic response from acquired resistance, 2018-05-23

• CoGAPS matrix factorization algorithm identifies transcriptional changes in AP-2alpha target genes in feedback from therapeutic inhibition of the EGFR network, 2016-09-16

• Patient choice for high-volume center radiation impacts head and neck cancer outcome, 2018-09-02

• Estimation of immune cell content in tumor using single-cell RNA-seq reference data, 2019-07-19

• Deciphering the Tumor-Immune-Microbe Interactions in HPV-Negative Head and Neck Cancer, 2023-08-08

• Phase II multi-institutional clinical trial result of concurrent cetuximab and nivolumab in recurrent and/or metastatic head and neck squamous cell carcinoma, 2022-06-01

• Locally advanced high-risk HPV related oropharyngeal squamous cell carcinoma (OPSCC); have we forgotten it is a different disease?, 2018-10-03

• NuKit: A deep learning platform for fast nucleus segmentation of histopathological images, 2023-03-11

• Autologous reconstitution of human cancer and immune systemin vivo, 2016-12-19